270 related articles for article (PubMed ID: 34477520)
1. Breast Cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/Cas9 System: An Oncogenetics Perspective.
Singh DD; Verma R; Tripathi SK; Sahu R; Trivedi P; Yadav DK
Curr Top Med Chem; 2021; 21(31):2800-2813. PubMed ID: 34477520
[TBL] [Abstract][Full Text] [Related]
2. Targeting RLIP with CRISPR/Cas9 controls tumor growth.
Singhal J; Chikara S; Horne D; Awasthi S; Salgia R; Singhal SS
Carcinogenesis; 2021 Feb; 42(1):48-57. PubMed ID: 32426802
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
5. New Insights into the Therapeutic Applications of CRISPR/Cas9 Genome Editing in Breast Cancer.
Ahmed M; Daoud GH; Mohamed A; Harati R
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34066014
[TBL] [Abstract][Full Text] [Related]
6. Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme.
Al-Sammarraie N; Ray SK
Cells; 2021 Sep; 10(9):. PubMed ID: 34571991
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer.
Deepak Singh D; Han I; Choi EH; Yadav DK
Comput Struct Biotechnol J; 2021; 19():2384-2397. PubMed ID: 34025931
[TBL] [Abstract][Full Text] [Related]
8. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
[TBL] [Abstract][Full Text] [Related]
9. Applications and advances of CRISPR/Cas9 in animal cancer model.
Xu M; Weng Q; Ji J
Brief Funct Genomics; 2020 May; 19(3):235-241. PubMed ID: 32124927
[TBL] [Abstract][Full Text] [Related]
10. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
12. Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.
Yoo KH; Hennighausen L; Shin HY
J Mammary Gland Biol Neoplasia; 2019 Mar; 24(1):47-59. PubMed ID: 30291498
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-Cas9 therapies in experimental mouse models of cancer.
Estêvão D; Rios Costa N; da Costa RG; Medeiros R
Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
[TBL] [Abstract][Full Text] [Related]
14. Development of a CRISPR/Cas9 System for Methylococcus capsulatus
Tapscott T; Guarnieri MT; Henard CA
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729
[TBL] [Abstract][Full Text] [Related]
15. CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.
Mintz RL; Gao MA; Lo K; Lao YH; Li M; Leong KW
Adv Biosyst; 2018 Nov; 2(11):. PubMed ID: 32832592
[TBL] [Abstract][Full Text] [Related]
16. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
Amritha PP; Shah JM
Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
19. Application of CRISPR/Cas9 gene editing technique in the study of cancer treatment.
Jiang C; Meng L; Yang B; Luo X
Clin Genet; 2020 Jan; 97(1):73-88. PubMed ID: 31231788
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-mediated targeting of HER2 inhibits cell proliferation through a dominant negative mutation.
Wang H; Sun W
Cancer Lett; 2017 Jan; 385():137-143. PubMed ID: 27815036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]